Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

ZYDUS PHARMS

  • FDA Approval
  • Aug. 20, 2024, 08:55 UTC
  • 49
  • 0 comments

FDA approve AMBRISENTAN

Comment Full text

MYLAN

  • FDA Approval
  • Aug. 20, 2024, 08:55 UTC
  • 62
  • 0 comments

FDA approve ESOMEPRAZOLE MAGNESIUM; NAPROXEN

Comment Full text

HETERO LABS LTD V

  • FDA Approval
  • Aug. 20, 2024, 08:55 UTC
  • 54
  • 0 comments

FDA approve SILODOSIN

Comment Full text

HERITAGE PHARMA

  • FDA Approval
  • Aug. 20, 2024, 08:55 UTC
  • 32
  • 0 comments

FDA approve DIFLUNISAL

Comment Full text

CIPLA

  • FDA Approval
  • Aug. 20, 2024, 08:55 UTC
  • 37
  • 0 comments

FDA approve AMBRISENTAN

Comment Full text

ENDO OPERATIONS

  • FDA Approval
  • Aug. 20, 2024, 08:55 UTC
  • 54
  • 0 comments

FDA approve AMBRISENTAN

Comment Full text

EDENBRIDGE PHARMS

  • FDA Approval
  • Aug. 20, 2024, 08:55 UTC
  • 48
  • 0 comments

FDA approve COLESTIPOL HYDROCHLORIDE

Comment Full text

SIGMAPHARM LABS LLC

  • FDA Approval
  • Aug. 20, 2024, 08:55 UTC
  • 41
  • 0 comments

FDA approve AMBRISENTAN

Comment Full text

GILEAD

  • FDA Approval
  • Aug. 20, 2024, 08:55 UTC
  • 48
  • 0 comments

FDA approve AMBRISENTAN

Comment Full text

MYLAN

  • FDA Approval
  • Aug. 20, 2024, 08:55 UTC
  • 44
  • 0 comments

FDA approve AMBRISENTAN

Comment Full text
  • Previous
  • 372
  • 373
  • 374
  • 375
  • 376
  • Next

Search

News categories

  • Technical Exchange News(14657)
  • Event(6229)
  • SEC News(390670)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(238186)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin